Delivery Order SPE2DB20D2014-SPE2DB25FA96E

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,051.98 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 27, 2024 with an ultimate completion date of November 29, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,325.77 firm fixed-price delivery order is for REPATHA 140 MG/ML SURECLICKML, a specialty medication. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,033.64, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of July 24, 2024 and is not set aside for a specific business type. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other agencies, such...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICK pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $2,819.14, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 24, 2024. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product REPATHA 140 MG/ML SURECLICK. The contract has a completion date of January 30, 2024 and a potential value of $1,525.23. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of REPATHA 140 MG/ML SURECLICKML, a cardiovascular medication. The $3,983.94 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, with a completion date of February 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,274.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, with a completion date of January 16, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of REPATHA 140 MG/ML SURECLICKML. The contract has a ceiling value of $2,211.29 and runs through December 31, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,016.82 firm fixed-price delivery order contract is for the supply of REPATHA 140 MG/ML SURECLICK medication. The contract has an ultimate completion date of October 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REPATHA 140 MG/ML SURECLICKML. The $3,139.31 firm-fixed-price delivery order has an ultimate completion date of August 4, 2023. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA96E
    Delivery Order

This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $2,103.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 3, 2025, with a completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/5/25, 9:53 AM